Dr. Willaiam A. Haseltine, Founder of Human Genome Sciences, Founder and Chair of ACCESS Health International, former Professor at Harvard Medical School and Dana-Farber Cancer Institute. He is the author of more than 200 peer-reviewed articles and Professor of Regenerative Medicine at the Feinstein Institutes for Medical Research. With over 50 years of experience, he has worked extensively with RNA. He co-discovered enhancers during his professional work at the Dana Farber Cancer Institute. Later, as founder and CEO of Human Genome Sciences, the company became the first in the world to isolate a complete set of protein-coding messenger RNAs and hundreds of thousands of other noncoding mRNAs. He continues to work on the fundamental role of RNA in biology and its medical applications.Dr. Roberto Patarca, MD, PhD is the Chief Medical Officer at ACCESS Health International,former faculty at Harvard Medical School and the University of Miami, and medical device company executive and has published over 100 manuscripts and nine books, served as Editor-in-Chief and Book Series Editor for Haworth Medical Press, and was elected member of the Academy of Sciences of Latin America. Their contributions have sparked progressive dialogues within the scientific community.

• 1.      Long noncoding RNAs: Characteristics, microprotein production, and genomic origins.-  2. Long noncoding RNAs: Localization, structure, and interactions with other molecules.- 3. Long noncoding RNAs in physiology and pathology.- 4. Small noncoding RNAs: Overview and microRNAs.- 5. Small noncoding RNAs: microRNAs in physiology and pathology.-  6. Small noncoding RNAs: Vault RNAs and agotrons.-  7. Small noncoding RNAs: Small interfering RNAs and Piwi-interacting RNAs.-  8. Small noncoding RNAs: Small nuclear RNAs, small nucleolar RNAs (snoRNAs), snoRNA-derived RNAs, small Cajal body-specific RNAs (scaRNAs), and Y RNAs.- 9. Small noncoding RNAs: Bacterial small regulatory RNAs (sRNAs), guide RNAs, small NF90 (ILF3) associated RNAs (SNARs), and miscellaneous small RNAs, including small-scan RNAs, bridge RNAs, and protein functional effector RNAs (pfeRNAs).

Dr. Willaiam A. Haseltine, Founder of Human Genome Sciences, Founder and Chair of ACCESS Health International, former Professor at Harvard Medical School and Dana-Farber Cancer Institute. He is the author of more than 200 peer-reviewed articles and Professor of Regenerative Medicine at the Feinstein Institutes for Medical Research. With over 50 years of experience, he has worked extensively with RNA. He co-discovered enhancers during his professional work at the Dana Farber Cancer Institute. Later, as founder and CEO of Human Genome Sciences, the company became the first in the world to isolate a complete set of protein-coding messenger RNAs and hundreds of thousands of other noncoding mRNAs. He continues to work on the fundamental role of RNA in biology and its medical applications.Dr. Roberto Patarca, MD, PhD is the Chief Medical Officer at ACCESS Health International,former faculty at Harvard Medical School and the University of Miami, and medical device company executive and has published over 100 manuscripts and nine books, served as Editor-in-Chief and Book Series Editor for Haworth Medical Press, and was elected member of the Academy of Sciences of Latin America. Their contributions have sparked progressive dialogues within the scientific community.

• 1.      Long noncoding RNAs: Characteristics, microprotein production, and genomic origins.-  2. Long noncoding RNAs: Localization, structure, and interactions with other molecules.- 3. Long noncoding RNAs in physiology and pathology.- 4. Small noncoding RNAs: Overview and microRNAs.- 5. Small noncoding RNAs: microRNAs in physiology and pathology.-  6. Small noncoding RNAs: Vault RNAs and agotrons.-  7. Small noncoding RNAs: Small interfering RNAs and Piwi-interacting RNAs.-  8. Small noncoding RNAs: Small nuclear RNAs, small nucleolar RNAs (snoRNAs), snoRNA-derived RNAs, small Cajal body-specific RNAs (scaRNAs), and Y RNAs.- 9. Small noncoding RNAs: Bacterial small regulatory RNAs (sRNAs), guide RNAs, small NF90 (ILF3) associated RNAs (SNARs), and miscellaneous small RNAs, including small-scan RNAs, bridge RNAs, and protein functional effector RNAs (pfeRNAs).

Dr. Willaiam A. Haseltine, Founder of Human Genome Sciences, Founder and Chair of ACCESS Health International, former Professor at Harvard Medical School and Dana-Farber Cancer Institute. He is the author of more than 200 peer-reviewed articles and Professor of Regenerative Medicine at the Feinstein Institutes for Medical Research. With over 50 years of experience, he has worked extensively with RNA. He co-discovered enhancers during his professional work at the Dana Farber Cancer Institute. Later, as founder and CEO of Human Genome Sciences, the company became the first in the world to isolate a complete set of protein-coding messenger RNAs and hundreds of thousands of other noncoding mRNAs. He continues to work on the fundamental role of RNA in biology and its medical applications.Dr. Roberto Patarca, MD, PhD is the Chief Medical Officer at ACCESS Health International,former faculty at Harvard Medical School and the University of Miami, and medical device company executive and has published over 100 manuscripts and nine books, served as Editor-in-Chief and Book Series Editor for Haworth Medical Press, and was elected member of the Academy of Sciences of Latin America. Their contributions have sparked progressive dialogues within the scientific community.

• 1.      Long noncoding RNAs: Characteristics, microprotein production, and genomic origins.-  2. Long noncoding RNAs: Localization, structure, and interactions with other molecules.- 3. Long noncoding RNAs in physiology and pathology.- 4. Small noncoding RNAs: Overview and microRNAs.- 5. Small noncoding RNAs: microRNAs in physiology and pathology.-  6. Small noncoding RNAs: Vault RNAs and agotrons.-  7. Small noncoding RNAs: Small interfering RNAs and Piwi-interacting RNAs.-  8. Small noncoding RNAs: Small nuclear RNAs, small nucleolar RNAs (snoRNAs), snoRNA-derived RNAs, small Cajal body-specific RNAs (scaRNAs), and Y RNAs.- 9. Small noncoding RNAs: Bacterial small regulatory RNAs (sRNAs), guide RNAs, small NF90 (ILF3) associated RNAs (SNARs), and miscellaneous small RNAs, including small-scan RNAs, bridge RNAs, and protein functional effector RNAs (pfeRNAs).